Skip directly to content

2.4. Referencias: Lumbalgia

BALAGUÉ F., MANNION A.F, PELLISÉ F. et al. Non-specif c low back pain. Lancet 2012; 379: 482–91

BHALA, N. et al. (2013) Vascular and upper GI effects of NSAIDs: Meta-analyses of individual participant data from randomized trials by the Coxib and traditional NSAID Trialists’ Collaboration. Lancet. 382. p.769-779 and Supplement.

CARDENAS-ESTRADA, E. et al. (2009) Efficacy and safety of celecoxib in the treatment of acute pain due to ankle sprain in a Latin American and Middle Eastern population. J Int Med Res. 37. p.1937-1951.

CHAN, F. K. et al. (2010) Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): A randomised trial. Lancet.[Online] p.1-7. Available from: [Accessed: 21st February 2013].

CHEUNG, R., KRISHNASWAMI, S., KOWALSKI, K. (2007) Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active and placebo-controlled study. Clin Ther. 29. p.2498-2510

CRYER, B. et al. (2013) GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trial. Am J Gastroenterol. 108 (3). p.392-400.

EMERY, P. et al. (1999) Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet. 354: p.2106-2111.

FREYNHAGEN, R. & BARON, R. (2009) The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 13 (3). p.185-190.

FREYNHAGEN, R. et al. (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin.22 (10). p.1911-1920

HOY D, MARCH L, BROOKS P, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study Ann Rheum Dis 2014;73:968–974

JENKINS, K. et al. FDA decision memorandum. Accessed November 03, 2014.

KOES BW, VAN TULDER MW, THOMAS S. Diagnosis and treatment of low back pain. BMJ 2006;332:1430–4

LEESE, P. T. et al. (2000) Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol. 40 (2). p.124-132.

MALLEN, SR, ESSEX MN, ZHANG R. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs. Curr Med Res Opin. 2011;27(7):1359-1366.

O’DONNELL, J. B. et al. (2009) The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: Results from two randomized, double-blind, 6-week studies. J Int Med Res. 37 (6). p.1-14.

PETRI, M. et al. (2004) Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis. J Rheumatol. 31. p.1614-1620.

ROMANO CL, ROMANO D, BONORO C., et al. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthopaed Traumatol (2009) 10:185–191

SCHROER, W. et al. (2011) Benefits of prolonged postoperative cyclooxygenase-2 inhibitor administration on total knee arthroplasty recovery. J Arthroplasty. 26 (6 Suppl. 1). p.2-7.

SIMON, L. S. et al. (1999) Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 282 (20): p.1921-1928.

SONI, P. et al. (2009) The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials. Curr Med Res Opin. 25 (8). p.1841-1851.

STRAND, V. et al. (2011) Treatment of osteoarthritis with continuous versus intermittent celecoxib. J Rheumatol. 38. p.2625-2634

WHELTON, A. et al. (2006) Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. Kidney Int. 70 (8). p.1495-1502.

WHITE, P. F. et al. (2007) Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. Can J Anaesth. 54 (5). p.342-348.

WILNER, K. D. et al. (2002) Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers. J Clin Pharmacol. 42 (9). p.1027-1030.




Este material es de uso exclusivo para el cuerpo médico.
©Pfizer S.A.S Todos los derechos reservados – Prohibida su reproducción total o parcial sin autorización del titular.